Archives of Toxicology

, Volume 85, Issue 10, pp 1189–1193 | Cite as

Quantitative cancer risk assessment for ethylene oxide inhalation in occupational settings

  • Ciriaco Valdez-Flores
  • Robert L. SielkenJr
  • M. Jane Teta
Regulatory Toxicology

Abstract

The estimated occupational ethylene oxide (EO) exposure concentrations corresponding to specified extra risks are calculated for lymphoid mortality as the most appropriate endpoint, despite the lack of a statistically significant exposure–response relationship. These estimated concentrations are for occupational exposures—40 years of occupational inhalation exposure to EO from age 20 to age 60 years. The estimated occupational inhalation exposure concentrations (ppm) corresponding to specified extra risks of lymphoid mortality to age 70 years in a population of male and female EO workers are based on Cox proportional hazards models of the most recent updated epidemiology cohort mortality studies of EO workers and a standard life-table calculation. An occupational exposure at an inhalation concentration of 2.77 ppm EO is estimated to result in an extra risk of lymphoid mortality of 4 in 10,000 (0.0004) in the combined worker population of men and women from the two studies. The corresponding estimated concentration decreases slightly to 2.27 ppm when based on only the men in the updated cohorts combined. The difference in these estimates reflects the difference between combining all of the available data or focusing on only the men and excluding the women who did not show an increase in lymphoid mortality with EO inhalation exposure. The results of sensitivity analyses using other mortality endpoints (all lymphohematopoietic tissue cancers, leukemia) support the choice of lymphoid tumor mortality for estimation of extra risk.

Keywords

Ethylene oxide Excess cancer risk calculation for occupational inhalation exposure NIOSH and UCC epidemiology data Cox proportional hazards models Lymphoid mortality 

Abbreviations

Dow

Dow Chemical Company

EO

Ethylene oxide

IARC

International Agency for Research on Cancer

NIOSH

National Institute for Occupational Safety and Health

SMR

Standardized mortality ratio

UCC

Union Carbide Corporation

Supplementary material

204_2011_669_MOESM1_ESM.pdf (88 kb)
Supplementary material 1 (PDF 87 kb)

References

  1. Albertini RJ (2009) Ethylene oxide low potency mutagen low potency carcinogen. Presentation: ethylene oxide session, Toxicology Forum, Aspen ColoradoGoogle Scholar
  2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2008) 1,3-butadiene, ethylene oxide and vinyl halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), vol 97. World Health Organization. International Agency for Research on Cancer. Lyon, FranceGoogle Scholar
  3. Kirman CR, Sweeney LM, Teta MJ, Sielken RL Jr, Valdez-Flores C, Albertini RJ, Gargas ML (2004) Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide. Risk Anal 24(5):1165–1183PubMedCrossRefGoogle Scholar
  4. Sielken RL Jr (2009) Use of pooled epidemiology data in quantitative risk assessment. Presentation: ethylene oxide session, Toxicology Forum, Aspen ColoradoGoogle Scholar
  5. Stayner L, Steenland K, Greife A, Hornung R, Hayes RB, Nowlin S, Morawetz J, Ringenburg V, Elliot L, Halperin W (1993) Exposure-response analysis of cancer mortality in a cohort of workers exposed to ethylene oxide. Am J Epidemiol 138:787–798PubMedGoogle Scholar
  6. Steenland K, Stayner L, Griefe A, Halperin B, Hayes R, Hornung R, Nowlin S (1991) A cohort mortality study of workers exposed to ethylene oxide. N Eng J Med 324(20):1402–1407CrossRefGoogle Scholar
  7. Steenland K, Stayner L, Deddens J (2004) Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: follow up extended from 1987 to 1998. Occup Environ Med 61:2–7PubMedGoogle Scholar
  8. Swaen GM, Burns C, Teta JM, Bodner K, Keenan D, Bodnar CM (2009) Mortality study update of ethylene oxide workers in chemical manufacturing: a 15 year update. J Occup Environ Med 51(6):714–723PubMedCrossRefGoogle Scholar
  9. Teta MJ, Benson LO, Vitale JN (1993) Mortality study of ethylene oxide workers in chemical manufacturing: a mortality study. Br J Ind Med 50:704–709PubMedGoogle Scholar
  10. Teta MJ, Sielken RL Jr, Valdez-Flores C (1999) Ethylene oxide cancer risk assessment based on epidemiologic data: application of revised regulatory guidelines. Risk Anal 19:1135–1155PubMedGoogle Scholar
  11. Valdez-Flores C, Sielken RL Jr, Teta MJ (2010) Quantitative cancer risk assessment based on NIOSH and UCC epidemiological data for workers exposed to ethylene oxide. Regul Tox Pharmacol 56:312–320CrossRefGoogle Scholar
  12. Vogel EW, Nivard M (1998) Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents. Mutat Res 400:509–540PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Ciriaco Valdez-Flores
    • 1
  • Robert L. SielkenJr
    • 1
  • M. Jane Teta
    • 2
  1. 1.Sielken & Associates Consulting Inc.BryanUSA
  2. 2.Exponent Health SciencesMiddleburyUSA

Personalised recommendations